Articles: PubMed:Poloxamine-cyclodextrin-simvastatin supramolecular systems promote osteoblast differentiation of mesenchymal stem cells. PubMed:Poloxamines for deswelling of organ-cultured corneas. PubMed:Osteogenic efficiency of in situ gelling poloxamine systems with and without bone morphogenetic protein-2. PubMed:Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. PubMed:Poloxamine-based nanomaterials for drug delivery. PubMed:Moisture-activated rheological structuring of nonaqueous poloxamine-poly(acrylic acid) systems designed as novel biomedical implants. PubMed:Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption. PubMed:Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). PubMed:Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908. PubMed:Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity. Implications in experimental and clinical oncology. PubMed:Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. PubMed:Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging. PubMed:Influence of the surfactant concentration on the body distribution of nanoparticles. PubMed:Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilization. PubMed:Cloud point of nonionic surfactants: modulation with pharmaceutical excipients. PubMed:Humoral-mediated recognition of 'phagocyte-resistant' beads by lymph node macrophages of poloxamine-treated rats. PubMed:Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres. PubMed:Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery. PubMed:A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats. PubMed:Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer. PubMed:Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo? PubMed:Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. PubMed:Thermally gelling poloxamine Synperonic T908 solution as a vehicle for rectal drug delivery. PubMed:Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. PubMed:Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats. PubMed:Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. PubMed:An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. PubMed:Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres. PubMed:The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.